Veeva Systems PE Ratio 2012-2025 | VEEV
Current and historical p/e ratio for Veeva Systems (VEEV) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veeva Systems PE ratio as of September 01, 2025 is 53.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Veeva Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-29 | 269.20 | 57.03 | |
| 2025-04-30 | 233.69 | $4.72 | 49.51 |
| 2025-01-31 | 233.26 | $4.33 | 53.87 |
| 2024-10-31 | 208.83 | $4.05 | 51.56 |
| 2024-07-31 | 191.93 | $3.75 | 51.18 |
| 2024-04-30 | 198.56 | $3.39 | 58.57 |
| 2024-01-31 | 207.41 | $3.22 | 64.41 |
| 2023-10-31 | 192.71 | $3.48 | 55.38 |
| 2023-07-31 | 204.22 | $3.32 | 61.51 |
| 2023-04-30 | 179.08 | $3.20 | 55.96 |
| 2023-01-31 | 170.55 | $3.01 | 56.66 |
| 2022-10-31 | 167.94 | $2.45 | 68.55 |
| 2022-07-31 | 223.58 | $2.43 | 92.01 |
| 2022-04-30 | 181.95 | $2.54 | 71.63 |
| 2022-01-31 | 236.54 | $2.63 | 89.94 |
| 2021-10-31 | 317.01 | $2.67 | 118.73 |
| 2021-07-31 | 332.71 | $2.62 | 126.99 |
| 2021-04-30 | 282.45 | $2.53 | 111.64 |
| 2021-01-31 | 276.44 | $2.36 | 117.14 |
| 2020-10-31 | 270.05 | $2.14 | 126.19 |
| 2020-07-31 | 264.57 | $2.06 | 128.43 |
| 2020-04-30 | 190.80 | $1.98 | 96.36 |
| 2020-01-31 | 146.61 | $1.91 | 76.76 |
| 2019-10-31 | 141.83 | $1.94 | 73.11 |
| 2019-07-31 | 165.90 | $1.83 | 90.66 |
| 2019-04-30 | 139.87 | $1.65 | 84.77 |
| 2019-01-31 | 109.06 | $1.47 | 74.19 |
| 2018-10-31 | 91.35 | $1.24 | 73.67 |
| 2018-07-31 | 75.63 | $1.05 | 72.03 |
| 2018-04-30 | 70.13 | $0.98 | 71.56 |
| 2018-01-31 | 62.86 | $0.93 | 67.59 |
| 2017-10-31 | 60.94 | $0.86 | 70.86 |
| 2017-07-31 | 63.76 | $0.79 | 80.71 |
| 2017-04-30 | 53.62 | $0.63 | 85.11 |
| 2017-01-31 | 42.33 | $0.48 | 88.19 |
| 2016-10-31 | 38.85 | $0.45 | 86.33 |
| 2016-07-31 | 37.99 | $0.37 | 102.68 |
| 2016-04-30 | 27.51 | $0.37 | 74.35 |
| 2016-01-31 | 24.10 | $0.37 | 65.14 |
| 2015-10-31 | 25.37 | $0.34 | 74.62 |
| 2015-07-31 | 26.92 | $0.34 | 79.18 |
| 2015-04-30 | 26.55 | $0.32 | 82.97 |
| 2015-01-31 | 28.76 | $0.28 | 102.71 |
| 2014-10-31 | 29.78 | $0.23 | 129.48 |
| 2014-07-31 | 23.80 | $0.21 | 113.33 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $43.991B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |